Skip to main content
main-content

01.12.2018 | Research article | Ausgabe 1/2018 Open Access

Breast Cancer Research 1/2018

Obesity promotes the expansion of metastasis-initiating cells in breast cancer

Zeitschrift:
Breast Cancer Research > Ausgabe 1/2018
Autoren:
Mélanie Bousquenaud, Flavia Fico, Giovanni Solinas, Curzio Rüegg, Albert Santamaria-Martínez
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1186/​s13058-018-1029-4) contains supplementary material, which is available to authorized users.
Curzio Rüegg and Albert Santamaria-Martínez contributed equally to this work.

Abstract

Background

Obesity is a strong predictor of poor prognosis in breast cancer, especially in postmenopausal women. In particular, tumors in obese patients tend to seed more distant metastases, although the biology behind this observation remains poorly understood.

Methods

To elucidate the effects of the obese microenvironment on metastatic spread, we ovariectomized C57BL/6 J female mice and fed them either a regular diet (RD) or a high-fat diet (HFD) to generate a postmenopausal diet-induced obesity model. We then studied tumor progression to metastasis of Py230 and EO771 grafts. We analyzed and phenotyped the RD and HFD tumors and the surrounding adipose tissue by flow cytometry, qPCR, immunohistochemistry (IHC) and western blot. The influence of the microenvironment on tumor cells was assessed by performing cross-transplantation of RD and HFD tumor cells into other RD and HFD mice. The results were analyzed using the unpaired Student t test when comparing two variables, otherwise we used one-way or two-way analysis of variance. The relationship between two variables was calculated using correlation coefficients.

Results

Our results show that tumors in obese mice grow faster, are also less vascularized, more hypoxic, of higher grade and enriched in CD11b+Ly6G+ neutrophils. Collectively, this favors induction of the epithelial-to-mesenchymal transition and progression to claudin-low breast cancer, a subtype of triple-negative breast cancer that is enriched in cancer stem cells. Interestingly, transplanting HFD-derived tumor cells in RD mice transfers enhanced tumor growth and lung metastasis formation.

Conclusions

These data indicate that a pro-metastatic effect of obesity is acquired by the tumor cells in the primary tumor independently of the microenvironment of the secondary site.

Graphical abstract

Effects of postmenopausal obesity on primary breast cancer tumoursᅟ
Zusatzmaterial
Additional file 1: Table S1. (DOCX 45.3 kb)
13058_2018_1029_MOESM1_ESM.docx
Additional file 2: Figure S1. Scheme of the experimental procedure (A). Body weight comparison between ovariectomized (n = 12 RD, n = 12 HFD) and non-ovariectomized (n = 5 RD, n = 5 HFD) mice (B). Body weight of ovariectomized RD and HFD mouse groups after 13 weeks of diet (C; n = 29 RD and n = 35 HFD). Data distribution of mouse weight in RD (D) and HFD (E) groups. Number of metastases seeded by same-sized tumors in RD and HFD mice (F and G). Error bars in panel B indicate SEM. (TIF 2261 kb)
13058_2018_1029_MOESM2_ESM.tif
Additional file 3: Figure S2. CD31 staining in C57BL/6 Rag2−/− mice show no differences between tumors from RD and HFD mice when they are grown in C57BL/6 Rag2−/− hosts (A, scalebar = 100uM). HIF1a staining in wild-type (wt) and C57BL/6 Rag2−/− mice show that hypoxia is increased in tumors from wt obese mice, while it is not changed in tumors in HFD-fed C57BL/6 Rag2−/− mice (B, scalebar 100 uM). HE staining of RD and HFD tumors showing enlarged nuclei and less packed chromatin in the latter (C, scalebar 50 um). IHC analyses in tumor samples show faster progression in HFD compared to RD tumors (D, n = 5, scalebar 50 um). (JPG 3325 kb)
13058_2018_1029_MOESM3_ESM.jpg
Additional file 4: Figure S3. FACS analyses show lower percentages of F4/80+ macrophages in the CD11b + compartment in Py230 HFD tumors (A, n = 18 RD, n = 20 HFD). Percentages of M1 (F4/80 + CD206-) and M2 macrophages (F4/80 + CD206+) identified in the CD11b + compartment of C57BL/6 and FVB/N mice (B, n = 3 RD, n = 7 HFD for C57BL/6 and n = 4 RD, n = 4 HFD for FVB/N). Normalized western blot analysis for CD11b in Py230-C57BL6 tumors (C; N = 8), Py230-C57BL/6;Rag2−/− tumors (D; N = 9) and PyMT-FVB/N tumors (E; n = 8). Clodronate liposomes treatment increases metastasis (F, n = 5 RD, n = 6 HFD). (TIF 1676 kb)
13058_2018_1029_MOESM4_ESM.tif
Additional file 5: Figure S4. Western blot analysis for E-cadherin, N-cadherin, p21, and HIF1a in Py230-C57BL/6 tumor lysates of RD and HFD (A). Western blot analysis for E-cadherin in PyMT tumors grown in FVB/N mice (B). Tumor weight of groups used for qPCR and western blot analyses (C, N = 10). CD11b strongly correlates with N-cadherin and anti-correlates with E-cadherin (D, N = 10). IHC on RD vs HFD tumors show nuclear p53 accumulation in the latter (E, scalebar 100 uM). qPCR analyses on Py230 RD and HFD tumors show significant downregulation of claudins and other cell-cell junction genes (F, n = 5). (TIF 9127 kb)
13058_2018_1029_MOESM5_ESM.tif
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2018

Breast Cancer Research 1/2018 Zur Ausgabe

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise